SRX Health Solutions Inc. (NYSE American: SRXH) reported its unaudited financial results for the first quarter ended December 31, 2025. Net sales for the period were USD 2.81 million. Gross profit was USD 1.05 million, reflecting a gross margin of 38%. Total operating expenses amounted to USD 4.84 million, leading to a loss from continuing operations of USD 3.79 million. Net interest expense was USD 1.29 million. The basic and diluted net loss per share was USD 0.26, with a weighted average of 33.74 million diluted shares outstanding during the quarter. As of December 31, 2025, SRX Health Solutions Inc. reported cash and cash equivalents of USD 13.06 million, up from USD 1.31 million at the previous quarter-end. Total current assets stood at USD 18.84 million. During and subsequent to the quarter, the company raised USD 16.10 million from the issuance of common stock and USD 8.90 million from preferred stock, partially offset by USD 8.50 million deployed into digital assets and USD 1.60 million used to repay convertible debt. SRX Health Solutions Inc. also deployed a total of USD 18 million into Bitcoin and Ethereum as part of its digital treasury strategy. The company executed a definitive agreement to acquire EMJ Crypto Technologies, a digital-asset treasury platform, with the transaction expected to close in the first half of calendar 2026. According to management commentary, funding constraints during the quarter led to temporarily reduced inventory levels and constrained sales of its U.S. pet wellness brand, Halo. The company reported that consumer demand remained resilient and indicated that normalized inventory levels would have supported year-over-year growth. SRX Health Solutions Inc. also noted efforts in SKU rationalization and exiting certain tariff-impacted products ahead of calendar 2026.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SRX Health Solutions Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202602131605PRIMZONEFULLFEED9654772) on February 13, 2026, and is solely responsible for the information contained therein.
Comments